Bank of America’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-16,100
Closed -$777K 7968
2021
Q1
$777K Buy
+16,100
New +$838K ﹤0.01% 5033

Other funds holding NEO

Bank of America's NEO Position: Q1 2026 in Review

Bank of America increased its NeoGenomics (NEO) stake by 127% in Q1 2026, buying an estimated $18M and bringing the position to 3,054,198 shares worth $22.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

Bank of America first reported a position in NEO in Q2 2013 and has held it in 52 quarters since. The position peaked at $63.7M in Q1 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Bank of America held 3,054,198 shares of NeoGenomics worth $22.7M as of Q1 2026.
  • Bank of America bought 1,706,472 NeoGenomics shares in Q1 2026, an estimated $18M.
  • NeoGenomics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2279 holding.
  • Bank of America first reported a position in NeoGenomics in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's NeoGenomics position peaked at $63.7M in Q1 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.